<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="066461-2018" EDITION="2018030"><TECHNICAL_SECTION><RECEPTION_ID>18-063428-001</RECEPTION_ID><DELETION_DATE>20180519</DELETION_DATE><FORM_LG_LIST>ES </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>30</NO_OJ><DATE_PUB>20180213</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 030-066461</NO_DOC_OJS><URI_LIST><URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:066461-2018:TEXT:ES:HTML</URI_DOC></URI_LIST><LG_ORIG>ES</LG_ORIG><ISO_COUNTRY VALUE="ES"/><IA_URL_GENERAL>http://madrid.org/contratospublicos</IA_URL_GENERAL><ORIGINAL_CPV CODE="33642000">Systemic hormonal preparations, excl. sex hormones</ORIGINAL_CPV><VALUES_LIST><VALUES TYPE="GLOBAL"><SINGLE_VALUE><VALUE CURRENCY="EUR">326 757,37</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">46 224,10</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">111 038,71</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">53 841,88</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">115 652,68</VALUE></SINGLE_VALUE></VALUES></VALUES_LIST><REF_NOTICE><NO_DOC_OJS>2017/S 124-251690</NO_DOC_OJS></REF_NOTICE></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180208</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="1">Open procedure</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01203</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Иcпaния</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Органически хормонални препарати, с изключение на половите хормони</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Španělsko</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Systémové hormonální přípravky kromě pohlavních hormonů</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Spanien</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Hormoner til systemisk brug, ekskl. kønshormoner</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Spanien</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Systemische Hormonpräparate, exkl. Sexualhormone und Insuline</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ισπανία</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Φάρμακα συστηματικών ορμονών, εξαιρουμένων των γεννητικών ορμονών</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Spain</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Systemic hormonal preparations, excl. sex hormones</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>España</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Preparados hormonales sistémicos, excluidas las hormonas sexuales</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Hispaania</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Süsteemsed hormoonpreparaadid, v.a suguhormoonid</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Espanja</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Systeemisesti käytettävät hormonivalmisteet, lukuun ottamatta sukupuolihormoneja</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Espagne</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Préparations hormonales systémiques, hormones sexuelles exclues</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Spáinn, an</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Systemic hormonal preparations, excl. sex hormones</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Španjolska</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Hormonski sustavni pripravci, osim spolnih hormona</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Spanyolország</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Szisztémás hormonális készítmények a nemi hormonok kivételével</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Spagna</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Preparati ormonali sistemici, esclusi gli ormoni sessuali</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Ispanija</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Sistemiškai veikiantys hormonų preparatai, išskyrus lytinius hormonus</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Spānija</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Hormonu preparāti sistēmiskai lietošanai, izņemot dzimumhormonus</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Spanja</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Preparazzjonijiet għas-sistema ormonali, esklużi l-ormoni tas-sess</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Spanje</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Sytemische hormoonpreparaten, geslachtshormonen uitgezonderd</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Hiszpania</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Ogólnoustrojowe preparaty hormonalne, z wyłączeniem hormonów płciowych</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Espanha</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Medicamentos hormonais sistémicos, exceptuando as hormonas sexuais</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Spania</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Preparate hormonale sistemice, cu excepţia hormonilor sexuali</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Španielsko</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Systémové hormonálne prípravky okrem pohlavných hormónov</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Španija</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Hormonski sistemski pripravki, razen spolnih hormonov</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Spanien</TI_CY><TI_TOWN>Getafe</TI_TOWN><TI_TEXT>Hormonpreparat för systemiskt bruk exkl. könshormoner</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="ES">Hospital Universitario de Getafe</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT_AWARD CATEGORY="ORIGINAL" FORM="3" LG="ES" VERSION="R2.0.8.S03.E01"><FD_CONTRACT_AWARD CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>Hospital Universitario de Getafe</OFFICIALNAME></ORGANISATION><ADDRESS>28905</ADDRESS><TOWN>Getafe</TOWN><POSTAL_CODE>28905</POSTAL_CODE><COUNTRY VALUE="ES"/><ATTENTION>BEGOÑA QUIJANO</ATTENTION><PHONE>+34 916247311</PHONE><E_MAILS><E_MAIL>sersum.hugf@salud.madrid.org</E_MAIL></E_MAILS><FAX>+34 916247239</FAX></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT_AWARD><URL_GENERAL>http://madrid.org/contratospublicos</URL_GENERAL></INTERNET_ADDRESSES_CONTRACT_AWARD></NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY VALUE="BODY_PUBLIC"/><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES><PURCHASING_ON_BEHALF><PURCHASING_ON_BEHALF_NO/></PURCHASING_ON_BEHALF></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><DESCRIPTION_AWARD_NOTICE_INFORMATION><TITLE_CONTRACT><P>PACP 2017-1-28 (MNU) Radiofármacos para medicina nuclear</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION_W_PUB><TYPE_CONTRACT VALUE="SUPPLIES"/></TYPE_CONTRACT_LOCATION_W_PUB><LOCATION_NUTS><LOCATION><P>Almacenes Generales del Hospital Universitario de Getafe.</P></LOCATION></LOCATION_NUTS><SHORT_CONTRACT_DESCRIPTION><P>PACP 2017-1-28 (MNU) Radiofármacos para medicina nuclear.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33642000"/></CPV_MAIN></CPV><CONTRACT_COVERED_GPA VALUE="NO"/></DESCRIPTION_AWARD_NOTICE_INFORMATION><TOTAL_FINAL_VALUE><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="326757.37">326 757,37</VALUE_COST><INCLUDING_VAT><VAT_PRCT FMTVAL="4.00">4,00</VAT_PRCT></INCLUDING_VAT></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></TOTAL_FINAL_VALUE></OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><TYPE_OF_PROCEDURE_DEF><PT_OPEN/></TYPE_OF_PROCEDURE_DEF><AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><AWARD_CRITERIA_DETAIL_F03><LOWEST_PRICE/></AWARD_CRITERIA_DETAIL_F03><F03_IS_ELECTRONIC_AUCTION_USABLE VALUE="NO"/></AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD><FILE_REFERENCE_NUMBER><P>PAPC 2017-1-28</P></FILE_REFERENCE_NUMBER><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3><PREVIOUS_PUBLICATION_EXISTS_F3><CNT_NOTICE_INFORMATION><CNT_NOTICE_INFORMATION_S CHOICE="CONTRACT_NOTICE"/><NOTICE_NUMBER_OJ>2017/S 124-251690</NOTICE_NUMBER_OJ><DATE_OJ><DAY>01</DAY><MONTH>07</MONTH><YEAR>2017</YEAR></DATE_OJ></CNT_NOTICE_INFORMATION><NO_OTHER_PREVIOUS_PUBLICATION/></PREVIOUS_PUBLICATION_EXISTS_F3></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3></ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD></PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><AWARD_OF_CONTRACT><CONTRACT_NUMBER>4624/2018</CONTRACT_NUMBER><CONTRACT_AWARD_DATE><DAY>17</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Iba Molecular Spain, S.A.U.</OFFICIALNAME></ORGANISATION><COUNTRY VALUE="ES"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="46224.10">46 224,10</VALUE_COST></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_YEARS>2</NUMBER_OF_YEARS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>4625/2018</CONTRACT_NUMBER><CONTRACT_AWARD_DATE><DAY>17</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Bayer Hispania, S.L.</OFFICIALNAME></ORGANISATION><COUNTRY VALUE="ES"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="111038.71">111 038,71</VALUE_COST><INCLUDING_VAT><VAT_PRCT FMTVAL="4.00">4,00</VAT_PRCT></INCLUDING_VAT></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_YEARS>2</NUMBER_OF_YEARS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>4626/2018</CONTRACT_NUMBER><CONTRACT_AWARD_DATE><DAY>17</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Mallinckrrodt Radiopharmaceuticals Spain, S.L.U.</OFFICIALNAME></ORGANISATION><COUNTRY VALUE="ES"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="53841.88">53 841,88</VALUE_COST><INCLUDING_VAT><VAT_PRCT FMTVAL="4.00">4,00</VAT_PRCT></INCLUDING_VAT></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_YEARS>2</NUMBER_OF_YEARS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>4627/2018</CONTRACT_NUMBER><CONTRACT_AWARD_DATE><DAY>17</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Ge Healthcare Bio-Sciences, S.A.</OFFICIALNAME></ORGANISATION><COUNTRY VALUE="ES"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="115652.68">115 652,68</VALUE_COST><INCLUDING_VAT><VAT_PRCT FMTVAL="4.00">4,00</VAT_PRCT></INCLUDING_VAT></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_YEARS>2</NUMBER_OF_YEARS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><COMPLEMENTARY_INFORMATION_CONTRACT_AWARD><RELATES_TO_EU_PROJECT_NO/><NOTICE_DISPATCH_DATE><DAY>08</DAY><MONTH>02</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_AWARD></FD_CONTRACT_AWARD></CONTRACT_AWARD></FORM_SECTION></TED_EXPORT>